Grand Pharmaceutical Group Ltd. (512) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sino Biopharmaceutical Ltd.

China Medical System Holdings Ltd.

WuXi AppTec Co., Ltd.

Simcere Pharmaceutical Group Ltd.

Grand Pharmaceutical Group Ltd.

Sinopharm Group Co., Ltd.

China Resources Pharmaceutical Group Ltd.

Hygeia Healthcare Holdings Co., Ltd.

China Traditional Chinese Medicine Holdings Co. Ltd.

HUTCHMED (China) Ltd.

Akeso, Inc.

Why is Grand Pharmaceutical Group Ltd. ?

Negative results in Jun 25

OPERATING CASH FLOW(Y) Lowest at HKD 3,317.62 MM
ROCE(HY) Lowest at 12.65%
RAW MATERIAL COST(Y) Grown by 8.87% (YoY)

With ROE of 11.71%, it has a Expensive valuation with a 2.03 Price to Book Value

Over the past year, while the stock has generated a return of 14.97%, its profits have risen by 1.6% ; the PEG ratio of the company is 11

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

13.34%

EBIT Growth (5y)

6.17%

EBIT to Interest (avg)

15.55

Debt to EBITDA (avg)

0.35

Net Debt to Equity (avg)

0.08

Sales to Capital Employed (avg)

0.53

Tax Ratio

14.29%

Dividend Payout Ratio

36.88%

Pledged Shares

Institutional Holding

ROCE (avg)

14.40%

ROE (avg)

14.09%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.03

EV to EBIT

16.37

EV to EBITDA

13.22

EV to Capital Employed

1.95

EV to Sales

2.97

PEG Ratio

11.01

Dividend Yield

2.77%

ROCE (Latest)

11.93%

ROE (Latest)

11.71%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 3.66 times

NET SALES(Q)

Highest at HKD 6,107.32 MM

-8What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD 3,317.62 MM

ROCE(HY)

Lowest at 12.65%

RAW MATERIAL COST(Y)

Grown by 8.87% (YoY

CASH AND EQV(HY)

Lowest at HKD 1,809.68 MM

DEBT-EQUITY RATIO (HY)

Highest at 16.34 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.49 times

Here's what is working for Grand Pharmaceutical Group Ltd.

Net Sales

Highest at HKD 6,107.32 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Inventory Turnover Ratio

Highest at 3.66 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation

Highest at HKD 285.42 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 285.42 MM has Grown at 12.11%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Grand Pharmaceutical Group Ltd.

Operating Cash Flow

Lowest at HKD 3,317.62 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Cash and Eqv

Lowest at HKD 1,809.68 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 16.34 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 2.49 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 8.87% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales